The Global Adherence Packaging Market is expected to reach USD 917.7 Million by 2022

According to a new market research report “Adherence Packaging Market, By System (Unit-dose, Multi-dose) Type (Blister Card, Pouch) Material (Plastic, Paper & Paperboard, Aluminum) End User (Retail, Long-term care facility, Hospital, Mail-order pharmacies) – Global Forecast to 2022” published by MarketsandMarkets™, the market is expected to grow at a CAGR of 6.2% between 2017 and 2022 to reach USD 917.7 million by 2022.
Browse 174 Market Data Tables and 31 Figures spread through 199 Pages and in-depth TOC on “Adherence Packaging Market”

https://marketsandmarketshealthcare.wordpress.com/2017/07/31/the-global-adherence-packaging-market-is-expected-to-reach-usd-917-7-million-by-2022/

Early buyers will receive 10% customization on this report

The growth in this market is mainly attributed to factors such as high rate of medication nonadherence, growing need to minimize medication wastage, and technological advancements such as remote dispensing systems.

By systems type, the multi-dose packaging systems segment accounted for the largest share of the market in 2016
On the basis of packaging systems, the market is categorized into multi-dose packaging systems and unit-dose packaging systems. The multi-dose packaging systems segment is further segmented into blister cards packaging systems and pouches/strips packaging systems. Similarly, the unit-dose packaging segment is further segmented into blister cards packaging systems and pouches/strips packaging systems. In 2016, the multi-dose packaging systems segment accounted for the largest share of the Adherence Packaging Market. The large share and high growth of this segment can primarily be attributed to the benefits of multi-dose packaging, such as assisting patients with complicated prescription regimens, ability to enhance patient safety, and elimination of medication waste.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=211268724

By packaging type & material, the blister cards segment & plastic film segment is expected to grow at the highest CAGR
By type, the global Adherence Packaging Market is segmented into blister cards and pouches/strips. By material, the global Adherence Packaging Market is segmented into plastic film, paper & paperboard, and aluminum. In 2016, the blister cards segment dominated the Adherence Packaging Market. Plastic film segment dominated the adherence packaging material market. Transparency, malleability, lightweight, and cost-effectiveness of plastic films are few of the factors driving the growth of this segment.

By end users, the retail pharmacies segment held the largest market share in 2016
The major end users of Adherence Packaging Market are retail pharmacies, long-term care facilities, hospitals, and mail-order pharmacies. In 2016, the retail pharmacies segment accounted for the largest share of the global Adherence Packaging Market.

North America dominated the market in 2016
In 2016, North America dominated the global Adherence Packaging Market. Rising prevalence of chronic diseases, increase in healthcare expenditure, rapid growth in the aging population, growing pharmaceuticals market, high rate of medication nonadherence, and an increase in funding by government agencies are driving the growth of the Adherence Packaging Market in North America.
The key players in the Adherence Packaging Market are Omnicell, Inc. (U.S.), McKesson Corporation (U.S.) , Becton, Dickinson and Company (U.S.), Parata Systems LLC (U.S), KUKA AG (Germany), TCGRx (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.), and Talyst Systems LLC. (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’ flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Bioabsorbable Stents Market worth 2.4 Billion USD by 2021

The report "Boiabsorbale Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in Europe, North America, Asia, and the Rest of the World (RoW).

Browse 88 market data tables with 43 figures spread through 126 pages and in-depth TOC on "Bioabsorbable Stents Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Forecast to 2021" 

https://marketsandmarketshealthcare.wordpress.com/2017/07/28/bioabsorbable-stents-market-worth-2-4-billion-usd-by-2021-2/

Early buyers will receive 10% customization on reports.

The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.

In this report, the bioabsorbable stents market is segmented on the basis of Material, absorption rate, application, end user, and region. Based on material, the market is segmented into polymer stents, and metallic stents. The polymer stents segment is expected to grow at the highest CAGR due to the various facts such as polymer-based bioabsorbable stents comprise PLLA polymers that are naturally biodegradable. These stents have a polymer coating of poly-D,L-lactide, which enables the controlled release of various drugs.

By absorption rate, the market is sub-segmented into fast and slow bioabsorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The growth in this segment is attributed to slow rate of absorption enables the longer duration of drug release within the arteries. This ensures efficient healing.

Geographically, the bioabsorbable stents market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.

The bioabsorbable stent market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Anesthesia Monitoring Devices Market worth 1,616 Million USD by 2020

The report "Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020", defines and segments the market with analysis and forecast of revenue. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is projected to reach USD 1,616 Million by 2020, at a CAGR of 12.0% from 2015 to 2020.

Browse 75 market data Tables and 83 Figures spread through 129 Pages and in-depth TOC on "Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020"
https://marketsandmarketshealthcare.wordpress.com/2017/07/27/anesthesia-monitoring-devices-market-worth-1616-million-usd-by-2020-2/

Early buyers will receive 10% customization on reports.

Anesthesia monitoring devices are available as a part of sophisticated multi-parameter patient monitors, or as a component of a high-end anesthesia workstation, or as a standalone unit. Technological changes as well as the growing usage of anesthesia monitors in the freestanding surgery centers are contributing to the increased growth of the anesthesia monitor devices market. The global market is expected to grow due to the rise in aging population, increasing number of surgeries, growing awareness among physicians, and advancements in technology. Despite this, high cost of anesthesia monitoring devices and the availability of conventional techniques are the major restraining factors of this market.

This market is segmented and forecasted on the basis of product, end user, and geography. The product comprises of advanced anesthesia monitors, basic anesthesia monitors, integrated anesthesia workstation, and others (IT enabled). The advanced anesthesia monitors are further subsegmented into anesthesia gas monitors, depth of anesthesia, standalone capnography monitors, and others (MRI compatible anesthesia monitors). On the basis of end user, the market is segmented into hospitals and ambulatory surgery centers. The market is further segmented and forecasted on the basis of major regions, which include North America, Europe, Asia-pacific and the rest of the world (RoW).

In 2014, 31.5% of the global anesthesia monitoring devices market was dominated by North America. The market in North America is growing due to increased patient safety and awareness among doctors and patients for low flow aesthetic agents. The European market, growing due to technological advancements, has been dominated majorly by Drägerwerk AG & Co. KGaA. However, the North American and European markets are moving toward the maturity phase.

This report also includes the market share, approaches for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis, and price analysis by product. In this report, market metrics are also included, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profile of key players in the market, including major companies which provide anesthesia monitoring devices as a product.

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Pain Management Devices Market worth 4.64 Billion USD by 2021

The report “ Pain Management Device Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) – Global Forecasts to 2021″, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on “Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) – Global Forecasts to 2021” 
https://wordpress.com/read/feeds/68945851/posts/1539234118
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Top 10 Medical Device Technologies Market worth 428.97 Billion USD by 2020

The report "Top 10 Medical Device Technologies Market by Type (IVD, Cardiology, Diagnostic Imaging, Orthopedics, Ophthalmology, Endoscopy, Diabetes Care, Wound Management, Kidney/Dialysis, and Anesthesia & Respiratory Care Devices) - Global Forecast to 2020", The Global Top 10 Medical Device technologies Market is Poised to Reach USD 428.97 Billion by 2020.                

Browse 321 market data tables and 57 figures spread through 383 pages and in-depth TOC on “Top 10 Medical Device Technologies Market by Type (IVD, Cardiology, Diagnostic Imaging, Orthopedics, Ophthalmology, Endoscopy, Diabetes Care, Wound Management, Kidney/Dialysis, and Anesthesia & Respiratory Care Devices) - Global Forecast to 2020"

https://wordpress.com/read/feeds/68945851/posts/1538043659

Early buyers will receive 10% customization on reports.

The growth in the top 10 medical devices industry is mainly driven by the rising prevalence of chronic lifestyle diseases like cardiovascular, diabetes, hypertension, cancer, and respiratory problems. Similarly, the rising acceptance of newer technologies by physicians & hospitals and growing geriatric population are also driving the overall growth of the top 10 medical devices market. However, factors such as uncertainty in reimbursement and the imposition of the medical device excise tax in the U.S. are restraining the growth of this market.

In this report, the top 10 medical device technologies market is segmented on the basis of type and region. On the basis of type, the market is segmented into IVD devices, cardiology devices, diagnostic imaging devices, orthopaedic devices, ophthalmology devices, endoscopy devices, diabetes care devices, wound management devices, kidney/dialysis devices, and anesthesia & respiratory care devices. In 2014, the IVD devices segment accounted for the largest share­—17.1%—of the global top 10 medical device technologies market, and is poised to grow at a CAGR of 5.8% during the forecast period. The large share of this segment is mainly attributed to the prevalence of diabetes, cardiovascular diseases, and cancer. Similarly, the rising incidence of respiratory infections, hospital-acquired infections, other infectious diseases, and sexually transmitted diseases are also driving the growth of this market.

However, anesthesia and respiratory care devices is the fastest-growing segment during the forecast period, growing at a CAGR of 8.7%. This segment accounted for a share of 6.7% of the global top 10 medical device technologies market in 2014.

Geographically, North America accounted for the largest share of ~39.7% of the top 10 medical device technologies market in 2014, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of North America in the global top 10 medical device technologies market is mainly attributed to greater accessibility to advanced technologies, rising prevalence of chronic lifestyle diseases, rising geriatric population, increasing number of surgical procedures, increasing acceptance of personalized medicine, and established distribution channels in this region as compared to Europe and APAC. However, the Asia-Pacific region is expected to be the fastest-growing top 10 medical device technologies market during the forecast period. Growing population in countries like China and India, rapid growth in geriatric population, improving healthcare infrastructure, growing per capita income, and rising focus of key market players on this region are contributing to the growth of the top 10 medical device technologies market in the APAC region during the forecast period.

The global top 10 medical device technologies market is fragmented in nature. Prominent players in this market include Johnson & Johnson (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Medtronic (U.S.), Philips Healthcare (Netherlands), Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Smith & Nephew plc (U.K.), Stryker Corporation (U.S.), and Boston Scientific Corporation (U.S.). The leading players in this market have built a strong market position over the years by focusing on new product launches; agreements, collaborations, and partnerships; and expanding their geographic presence in emerging markets in order to widen their revenue streams. These still remain the actively adopted strategies by leading players in this market, in order to achieve sustainable revenue growth in the competitive top 10 medical devices market.

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441

Email: sales@marketsandmarkets.com

Optical Imaging Market worth 1.75 Billion USD by 2020

The report “Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) – Global Forecast to 2020″, The Global Optical Imaging Market Is Expected to reach USD 1,749.2 Million by 2020. The market was valued at USD 989.0 Million in 2015 and is expected to grow at a CAGR of 12.1% from 2015 to 2020.

Browse 161 market data Tables and 43 Figures spread through 200Pages and in-depth TOC on “Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) – Global Forecast to 2020”

 https://wordpress.com/read/feeds/68945851/posts/1534098074

Early buyers will receive 10% customization on reports.

Owing to the technological advancements and increasing application areas of optical imaging techniques in pharmaceutical and biotechnological industries and medical diagnostics & therapeutics, the optical imaging market recorded a healthy growth rate during last decade. Optical imaging is extensively used for several applications including preclinical research, disease diagnosis, imaging of various cellular and molecular processes in vivo including protein interactions, protein degradation, and protease activity. Thus, increasing research activities in the biopharmaceutical industry and rising applications of optical imaging modalities for therapeutic and diagnostic purposes is expected to have a positive impact on the growth of this market. Moreover, uptake of optical imaging techniques due to growing demand for non-invasive & non-ionizing imaging modalities with ageing population and integration of optical imaging techniques with other imaging modalities is expected to drive the demand for optical imaging products in the coming years. However, high installation cost, complex regulatory requirements, and lack of skilled operators is likely to hinder the growth of the market to a certain extent.

In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets.

In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substantial growth opportunity for the optical imaging market during the forecast period of 2015 to 2020. The growth in this region is primarily driven by increased focus on healthcare growth in geriatric population, rising per capita income, increasing investments in the APAC healthcare industry by key market players, rising demand for cutting-edge technologies, and low labor costs.

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Bioptigen, Inc. (U.S.), Topcon Medical Systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Canon, Inc. (U.S.), and PerkinElmer, Inc. (U.S.),

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Downstream Bioprocessing Market and Downstream Processing in Biopharmaceuticals worth 22.03 Billion USD by 2021

The report "Downstream Bioprocessing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021", provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Browse 68 market data tables and 40 figures spread through 139 pages and in-depth TOC on "Downstream Bioprocessing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021"

http://www.marketsandmarkets.com/Market-Reports/downstream-processing-market-73180930.html
Early buyers will receive 10% customization on reports.

The Downstream Bioprocessing Market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

The growth in the Downstream Bioprocessing Market will majorly be driven by the increasing demand for biopharmaceuticals, as downstream processing steps play a significant role in providing pure and quality products. However, the high cost of instruments used in downstream processing is expected to restrain the growth of this market. On the other hand, patent expiration of blockbuster biopharmaceutical products represents significant growth opportunities for the key players in the downstream processing market.

TheDownstream Bioprocessing Market is broadly segmented on the basis of technique, product, application, end user, and region. On the basis of technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This largest share and the high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

On the basis of product, the market is broadly classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products (consumables and accessories). In 2016, the chromatography columns and resins segment accounted for the largest share of the downstream processing market. Columns and resins are the most important component of a chromatography system and are extensively used in the separation, recovery, and purification of components of a bioactive sample. The constant need for newer and different types of columns and resins is likely to fuel market growth.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the Downstream Bioprocessing Market in 2016, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The Asia-Pacific downstream processing market, particularly in China, Japan, India, and South Korea, is expected to witness high growth. In addition, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise & academic excellence.

The downstream processing market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).